Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc > Core One mgmt, get on with it

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Jun 24, 2022 4:27pm

206 Views

Post# 34781338

RE:RE:RE:Core One mgmt, get on with it

I thought they had reported in the past that they were going to license out the strip tech for cannabis/other use while scaled psilocybin production is pending...but apparently that never happened because it makes too much sense? Need revs...

lscfa wrote: The strip tech will now be used to administer psilocybin.....

CancerSlayer wrote:

lscfa wrote:
Demand for psilocybin is there so start competing with its synthetic product.

https://www.globenewswire.com/news-release/2022/05/27/2451998/0/en/Optimi-Health-Signs-Psilocybin-Supply-Agreement-With-Halucenex-Life-Sciences-Inc.html

Is COOL's synthetic product even scalable? And could they even get friendly financing to scale it up? What happened to generating revs from their Cannastrip machine? I think they are no more than a micro R&D company in a very small & highly regulated/non-commercial niche that is just hoping for a big payday/buyout. The only problem is...their is no serious/legitimate Pharma player (outside of another cannabis/nutraceutical co.) that would be willing to even negotiate, let alone pay the right price for the owners of COOL. Now that financials have been delayed again, confidence must be at an all time low. JMHO.